|
|
Volumn 75, Issue 10, 2014, Pages e26-
|
|
Pros and cons of approved therapies for bipolar depression and ongoing unmet needs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
DIBENZOTHIAZEPINE DERIVATIVE;
DRUG COMBINATION;
FLUOXETINE;
FLUOXETINE PLUS OLANZAPINE;
ISOINDOLE DERIVATIVE;
LURASIDONE;
NEUROLEPTIC AGENT;
QUETIAPINE;
THIAZOLE DERIVATIVE;
BIPOLAR DISORDER;
DRUG COMBINATION;
HUMAN;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
BIPOLAR DISORDER;
DIBENZOTHIAZEPINES;
DRUG COMBINATIONS;
FLUOXETINE;
HUMANS;
ISOINDOLES;
THIAZOLES;
|
|
EID: 84922393127
PISSN: None
EISSN: 15552101
Source Type: Journal
DOI: 10.4088/JCP.13019tx4c Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|